HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Regeneron · Phase 2 · Active, not recruiting · Enrollment 120
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.